Opin vísindi

Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies

Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies


Title: Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies
Author: Lifelines Cohort Study
Date: 2022-09
Language: English
Scope: 16
School: Health Sciences
Department: Clinical Laboratory Services, Diagnostics and Blood Bank
Faculty of Medicine
Series: Kidney International; 102(3)
ISSN: 0085-2538
DOI: https://doi.org/10.1016/j.kint.2022.05.021
Subject: Lífefna- og sameindalíffræði; acute kidney injury; chronic kidney disease; diabetes; gene expression; Nephrology
URI: https://hdl.handle.net/20.500.11815/3851

Show full item record

Citation:

Lifelines Cohort Study 2022 , ' Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies ' , Kidney International , vol. 102 , no. 3 , pp. 624-639 . https://doi.org/10.1016/j.kint.2022.05.021

Abstract:

Estimated glomerular filtration rate (eGFR) reflects kidney function. Progressive eGFR-decline can lead to kidney failure, necessitating dialysis or transplantation. Hundreds of loci from genome-wide association studies (GWAS) for eGFR help explain population cross section variability. Since the contribution of these or other loci to eGFR-decline remains largely unknown, we derived GWAS for annual eGFR-decline and meta-analyzed 62 longitudinal studies with eGFR assessed twice over time in all 343,339 individuals and in high-risk groups. We also explored different covariate adjustment. Twelve genome-wide significant independent variants for eGFR-decline unadjusted or adjusted for eGFR-baseline (11 novel, one known for this phenotype), including nine variants robustly associated across models were identified. All loci for eGFR-decline were known for cross-sectional eGFR and thus distinguished a subgroup of eGFR loci. Seven of the nine variants showed variant-by-age interaction on eGFR cross section (further about 350,000 individuals), which linked genetic associations for eGFR-decline with age-dependency of genetic cross-section associations. Clinically important were two to four-fold greater genetic effects on eGFR-decline in high-risk subgroups. Five variants associated also with chronic kidney disease progression mapped to genes with functional in-silico evidence (UMOD, SPATA7, GALNTL5, TPPP). An unfavorable versus favorable nine-variant genetic profile showed increased risk odds ratios of 1.35 for kidney failure (95% confidence intervals 1.03-1.77) and 1.27 for acute kidney injury (95% confidence intervals 1.08-1.50) in over 2000 cases each, with matched controls). Thus, we provide a large data resource, genetic loci, and prioritized genes for kidney function decline, which help inform drug development pipelines revealing important insights into the age-dependency of kidney function genetics.

Description:

Funding Information: The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) supported the meta-analysis—project identifier 387509280 —SFB1350 (subproject C6 to IMH). We conducted this research using the UK Biobank resource under the application number 20272. Extended acknowledgements and funding information are provided in the online Supplementary Material . Publisher Copyright: © 2022 International Society of Nephrology

Files in this item

This item appears in the following Collection(s)